19.30CHF+5.58%Mkt Cap: 868.74M $P/E: 321.671d ago
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two se…
Indicators:|
Key Statistics
Company
Market Cap868.74M $
Enterprise Value841.50M $
Revenue (TTM)166.70M $
Gross Profit147.69M $
Net Income (TTM)2.91M $
Revenue/Share4.337 USD
Last Price19.30 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees178
CountryCH
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)321.67
P/E (Forward)44.37
PEG—
EV/EBITDA64.00
EV/Revenue5.05
P/S5.21
P/B11.04
EPS (TTM)0.06
EPS (Forward)0.43
52W Range
17.6910% of range34.20
52W High34.20 CHF
52W Low17.69 CHF
Profitability
Gross Margin88.60%
Oper. Margin6.59%
EBITDA Margin7.89%
Profit Margin1.75%
ROE3.02%
ROA1.91%
Growth
Revenue Growth66.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-519.29K $
CapEx (TTM)2.78M $
FCF Margin-2.69%
FCF Yield-0.52%
Net Debt-20.98M $
Net Debt/EBITDA-1.60
Balance Sheet
Debt/Equity0.02
Current Ratio1.96
Quick Ratio1.42
Book Value/Sh1.748 CHF
Cash/Share0.5050 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 8, 2020
Splits
Last Split1:100
Split DateJun 23, 2016
Analyst Consensus
Rating—
Target (Mean)35.40 CHF
Upside (mean)+83.4%
Target Range32.80 CHF – 38.00 CHF
CHF32.80+83.4% to meanCHF38.00
# Analysts2
Ownership
Shares Out.39.44M
Float28.94M
Insiders28.91%
Institutions22.78%
Technical
SMA 5020.43 (-5.5%)
SMA 20025.35 (-23.9%)
Beta0.70
S&P 52W Chg20.05%
Avg Vol (30d)204.79K
Avg Vol (10d)215.34K
Technical Indicators
RSI (14)47.1
MACD-0.6598
MACD Signal-0.6404
MACD Hist.-0.0194
BB Upper21.37 CHF
BB Middle19.40 CHF
BB Lower17.42 CHF
BB Width20.40%
ATR (14)1.080 CHF
Vol Ratio (20d)0.79x